Look Ahead: Cosmetics

Pallone To Focus On Cosmetics Reform, As FDA Tackles Safety Issues

By Kelly Lienhard / January 14, 2020 at 1:21 PM

Cosmetics regulatory reform is a priority for House Energy & Commerce Committee Chair Frank Pallone (D-NJ) in 2020, an E&C spokesperson told Inside Health Policy.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.